2018 - Member of Academia Europaea
Her primary scientific interests are in Cell biology, Biochemistry, Substrate reduction therapy, Glycosphingolipid and Sphingolipid. She has included themes like CD1D, Lysosome and Autophagy in her Cell biology study. Her Substrate reduction therapy research is multidisciplinary, incorporating elements of GM2 gangliosidoses, Endocrinology and Miglustat.
Her Glycosphingolipid research is multidisciplinary, relying on both High-performance liquid chromatography, Mutant, Pharmacology and In vivo. Her Sphingolipid study incorporates themes from Lysosomal storage disease, Endocytic cycle and Sphingosine. Her biological study spans a wide range of topics, including Gastroenterology and Surgery.
The scientist’s investigation covers issues in Biochemistry, Cell biology, Internal medicine, Immunology and NPC1. Her Cell biology study which covers Lysosome that intersects with Neurodegeneration. Her work in Internal medicine addresses subjects such as Endocrinology, which are connected to disciplines such as Ganglioside.
Her Immunology research focuses on subjects like Sandhoff disease, which are linked to Gangliosidosis and Ganglioside GM2. Her NPC1 research integrates issues from Lysosomal storage disease and Niemann–Pick disease, type C. Frances M. Platt has researched Glycosphingolipid in several fields, including Substrate reduction therapy and In vivo.
Frances M. Platt spends much of her time researching NPC1, Cell biology, Niemann–Pick disease, type C, Internal medicine and Lysosome. The various areas that Frances M. Platt examines in her NPC1 study include Vesicle, Sphingolipid, Biophysics, Mutant and Exocytosis. Her Cell biology research focuses on Endosome in particular.
The concepts of her Niemann–Pick disease, type C study are interwoven with issues in Adult patients, Miglustat and Clinical severity. Her Internal medicine research includes elements of Experimental therapy and Endocrinology. Her Lysosome research incorporates elements of Juvenile, Dystrophy, Neurodegeneration, Neuron death and Late endosome.
Her scientific interests lie mostly in Neurodegeneration, Lysosome, Genetic enhancement, NPC1 and Cell biology. Frances M. Platt works mostly in the field of Neurodegeneration, limiting it down to topics relating to Glucocerebrosidase and, in certain cases, Immunology, Cre recombinase and Enzyme replacement therapy, as a part of the same area of interest. Her Lysosome research is multidisciplinary, relying on both Endocrinology, Internal medicine and Parkinson's disease.
Her NPC1 study incorporates themes from Miglustat and Niemann–Pick disease. Frances M. Platt has included themes like Disease Pathway, Substrate reduction therapy, Transgene and Niemann–Pick disease, type C in her Niemann–Pick disease study. Her study in the field of Endosome is also linked to topics like TLR9.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
Timothy J. McDonnell;Natasha Deane;Frances M. Platt;Gabriel Nunez.
Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease
B Boland;A Kumar;S Lee;F M Platt.
The Journal of Neuroscience (2008)
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
T Cox;R Lachmann;C Hollak;J Aerts.
The Lancet (2000)
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
Emyr Lloyd-Evans;Anthony J Morgan;Xingxuan He;David A Smith.
Nature Medicine (2008)
The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.
Frances M. Platt;Barry Boland;Aarnoud C. van der Spoel.
Journal of Cell Biology (2012)
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
F M Platt;G R Neises;R A Dwek;T D Butters.
Journal of Biological Chemistry (1994)
Targeting glycosylation as a therapeutic approach
Raymond A. Dwek;Terry D. Butters;Frances M. Platt;Nicole Zitzmann.
Nature Reviews Drug Discovery (2002)
Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N-Butyldeoxynojirimycin
F M Platt;G R Neises;G Reinkensmeier;M J Townsend.
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
Nicole Zitzmann;Anand S. Mehta;Sandra Carrouée;Terry D. Butters.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
M. Jeyakumar;R. Thomas;E. Elliot‐Smith;D. A. Smith.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: